This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $68,514.54 firm fixed-price delivery order is for the supply of the drug TRIKAFTA 100-50-75 MG/150 MG, with a performance period through August 2, 2024.
DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military healthcare facilities worldwide. This contract does not have a set-aside designation. Through this IDC and other prime vendor contracts, DMS Pharmaceutical Group provides both routine and critical medications, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to the Department of Defense and Department of Veterans Affairs.
Generated 10/31/24, 10:43 AM